Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832909 · ClinicalTrials.gov registry record · NA
The Measured Energy Value of Walnuts in the Human Diet
A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01832909: Completed NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
NCT01832909 is a NA study that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01832909, a NA study, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objective of this study is to measure the energy value of walnuts in the human diet and study molecular mechanisms that may help explain the beneficial health effects of walnuts. The hypothesis is that there will be less metabolizable energy in walnuts due to decreased fat digestibility.
Primary Outcome
Metabolizable energy content will be calculated according to the methods of Novotny et al. (2012). Fat, protein, and fiber digestibility will be calculated and the effect of walnuts on nutrient digestibility will be assessed.
Interventions
- OTHER Control Diet
- OTHER Walnut Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01832909 record still lists
NCT01832909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Diet is the first listed.
NCT01832909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01832909 about?
NCT01832909 is a clinical study titled "The Measured Energy Value of Walnuts in the Human Diet". The objective of this study is to measure the energy value of walnuts in the human diet and study molecular mechanisms that may help explain the beneficial health effects of walnuts. The hypothesis is that there will be less metabolizable energy in walnuts due to decreased fat digestibility.
What is the current status of trial NCT01832909?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2013-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01832909?
The interventions under investigation include: Control Diet (OTHER), Walnut Diet (OTHER).
Who is sponsoring clinical trial NCT01832909?
This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01832909's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia